KimberlyGail DicuccioHeckertMD

Physical Medicine/Rehab • Philadelphia, PA

Neurorehabilitation, Brain Injury Medicine

Physician

Join to view full profile

Dr. Heckert is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Heckert's full profile

Already have an account?

Office
130 S 9th St
Philadelphia, PA 19107
Phone+1 215-606-4888

Fax+1 215-923-6808

Education & Training

University of Medicine and Dentistry of New JerseyStroke & Brain Injury Rehabilitation, 2007 - 2008
Sidney Kimmel Medical College at Thomas Jefferson University/TJUHResidency, Physical Medicine and Rehabilitation, 2004 - 2007
UPMC Medical Education (Mercy)Internship, Transitional Year, 2003 - 2004
Sidney Kimmel Medical College at Thomas Jefferson UniversityClass of 2003

Certifications & Licensure

NJ State Medical License 2006 - 2025
PA State Medical License 2003 - 2024
NY State Medical License 2008 - 2010
American Board of Physical Medicine and Rehabilitation Physical Medicine & Rehabilitation
American Board of Physical Medicine and Rehabilitation Brain Injury Medicine

Publications & Presentations

PubMed

1 citations
Delphi Analysis: Optimizing Anatomy Teaching and Ultrasound Training for Botulinum Neurotoxin Type A Injection in Spasticity and Dystonia.
Kimberly Heckert, Bo Biering-Sørensen, Tobias Bäumer, Omar Khan, Fernando Pagan
Toxins. 2024-08-21
2 citations
The Dearth of Disability Medical Education and a Partial Solution.
Michael D Stillman, Michael Mallow, Nethra Ankam, Jason Ojeda, Mary Stephens
Teaching and Learning in Medicine. 2022-09-09
1 citations
Atypical Presentation of Myotonic Dystrophy Type 1
Kimberly DiCuccio Heckert, Robert S. Skerker
PM & R. 2011-04-01

Press Mentions

JAMA Dermatology Publishes Data Showing RINVOQ® (Upadacitinib) Achieved Superiority Versus DUPIXENT® (Dupilumab) for Primary and All Ranked Secondary Endpoints in Phase 3b Head-to-Head Study in Adults with Atopic DermatitisAugust 4th, 2021
Botox Approved to Treat Spasticity in 8 New Arm, Hand MusclesAugust 2nd, 2021
AbbVie (ABBV) Announces FDA Approves Expanded BOTOX Label to Include Eight New Muscles to Treat Adults with Upper Limb SpasticityJuly 29th, 2021